Karyopharm announces xpovio® (selinexor) data to be presented at the european hematology association 2021 virtual congress

Newton, mass., june 9, 2021 /prnewswire/ -- karyopharm therapeutics inc. (nasdaq: kpti), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that nine abstracts have been selected for virtual presentation, including one oral presentation, at the upcoming european hematology association (eha) 2021 virtual congress taking place june 9-17, 2021.
KPTI Ratings Summary
KPTI Quant Ranking